Manabu Kanai

Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial

Yoshiaki Oda, Yuji Kumagai, Manabu Kanai et al. · The Lancet Infectious Diseases · 2023 · 99 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +8

Determination of Urinary and Serum Pentosidine and Its Application to Elder Patients.

Kazuhiro Yoshihara, Kyoko Nakamura, Manabu Kanai et al. · Biological and Pharmaceutical Bulletin · 1998 · 44 citations · Full text

Aging, Dermatology, Renal Function +17

Persistence of immune responses of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2

Yoshiaki Oda, Yuji Kumagai, Manabu Kanai et al. · The Lancet Infectious Diseases · 2024 · 44 citations · Full text

Vaccination, Vaccine Development, Versus Bnt162b2 +7

Dynamic light-scattering and preliminary crystallographic studies of the sensor domain of the haem-based oxygen sensor FixL from <i>Rhizobium meliloti</i>

Hideyuki Miyatake, Manabu Kanai, Shin‐ichi Adachi et al. · Acta Crystallographica Section D Biological Crystallography · 1999 · 12 citations

An attempt to control lipid peroxidation in the tissues of yellowtails and to enhance their biological protective ability by feeding high .ALPHA.-tocopherol brown meals.

Tomohiro Sekiya, Hisashi Murata, Tadashi Sakai et al. · NIPPON SUISAN GAKKAISHI · 1991 · 10 citations · Full text